Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
117,272,814
-
Share change
-
+6,463,572
-
Total reported value
-
$9,726,205,378
-
Put/Call ratio
-
153%
-
Price per share
-
$82.93
-
Number of holders
-
617
-
Value change
-
+$539,755,864
-
Number of buys
-
206
-
Number of sells
-
374
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2025
As of 30 Jun 2025,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
617 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
117,272,814 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, CITIGROUP INC, HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND, MORGAN STANLEY, JPMORGAN CHASE & CO, BNP PARIBAS FINANCIAL MARKETS, BANK OF AMERICA CORP /DE/, UBS Group AG, WELLS FARGO & COMPANY/MN, and CANADA PENSION PLAN INVESTMENT BOARD.
This page lists
618
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.